Open AccessRegarding “Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies”
Author(s) -
Chabner Bruce A.
Publication year - 2017
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2017-0202
Subject(s) - medicine , food and drug administration , drug , drug approval , intensive care medicine , cancer drugs , drug development , oncology , pharmacology
This editorial reflects on improvements in the cancer drug approval process of the U.S. Food and Drug Administration.